Business

Boustead Holdings records Q1 net loss of RM62.80 mil

Shortfall largely due to one-off gain in same quarter in same period last year, says group

Updated 11 months ago · Published on 29 May 2023 9:34PM

Boustead Holdings records Q1 net loss of RM62.80 mil
In a filing with Bursa Malaysia, Boustead Holdings Bhd says the group recorded a loss before taxation and zakat of RM15.9 million as compared to profit before taxation and zakat of RM683.1 million posted in Q1 FY2022. – ABDUL RAZAK LATIF/The Vibes file pic, May 29, 2023

KUALA LUMPUR – Boustead Holdings Bhd (BHB) registered a net loss of RM62.80 million for the first quarter ended March 31, 2023 (Q1 FY2023), from a net profit of RM290.30 million in the same period last year.

Revenue decreased marginally to RM3.24 billion from RM3.44 billion previously, as only the trading, finance and investment division registered a higher revenue.

In a filing with Bursa Malaysia, BHB said the group recorded a loss before taxation and zakat (LBT) of RM15.9 million as compared to profit before taxation and zakat (PBT) of RM683.1 million posted in Q1 FY2022.

It said the shortfall was mainly due to a one-off gain achieved in Q1 FY2022 for the disposal of plantation assets and weaker operational results due to the decrease in palm product prices and unfavourable impact on the valuation of fresh fruit bunches.

“The plantation division registered a lower PBT of RM13.5 million from RM509.5 million previously, mainly due to a one-off gain on disposal of plantation assets of RM364.1 million recognised in Q1 FY2022,” it said.

BHB said its pharmaceutical division posted a reduced PBT of RM9.3 million from RM36.9 million previously, as revenue was affected by lower customer demand in both concession and Indonesian segments.

On prospects, the group said it is optimistic that the gradual return of migrant workers, together with the progress of its Plantation Performance Improvement Programs, the relaxation of regulations for migrant workers and its Reinventing Boustead strategy that emphasises mechanisation and digitalisation, will improve yields, and can partially offset the impact of lower crude palm oil prices and rising costs.

BHB said the pharmaceutical division is poised to penetrate the Indonesian market further and reinforce its position as a leading healthcare provider in the region.

“In order to exit from the PN17 status, the division, together with its principal adviser, is working on the regularisation plan to improve the shareholders’ equity of Pharmaniaga Bhd.

“It is targeted that the PN17 issue will be settled by Q1 2024,” it said.

In a separate statement filed with the exchange, BHB said the Ministry of Finance (Incorporated) has the intention to acquire 20.8% of Boustead Heavy Industries Corp Bhd’s entire equity interest in Boustead Naval Shipyard Sdn Bhd, held via its wholly owned subsidiary, Perstim Industries Sdn Bhd.

“The terms of the proposed acquisition are subject to negotiations between the parties,” it added. – Bernama, May 29, 2023

Related News

Business / 10mth

Boustead redesignates Nazim Rahman as executive chair

Malaysia / 10mth

Khazanah’s RM165 mil Kidzania S’pore sells for RM379,000

Business / 11mth

LTAT completes takeover of Boustead Holdings

Business / 1y

Privatisation headlines fuel rally in Boustead stocks

Business / 1y

Boustead appoints Ahmad Nazim as chairman

Business / 1y

Bersatu’s Redzuan resigns as Boustead Holdings chair

Spotlight

Malaysia

PRS proposes party president to fill vacant Senate president’s post

Malaysia

Ex-inspector escapes gallows, gets 33 years for wife’s murder

Malaysia

Foreigners make up 10% of Malaysia population

Malaysia

Cop pleads not guilty to student’s murder

Malaysia

Banks warn about scammers who impersonate NSRC officers

Malaysia

Jeffrey recalls memories of ISA confinement 33 years later

By Jason Santos